In the study cohort, ITGβ-1 levels were detected below the cut-off value in 47 healthy individuals and 21 glioma patients, while 3 healthy individuals and 79 patients had levels exceeding this threshold. The gene discussed is ITGB1; the disease is central nervous system cancer.